![]() Benzinga does not provide investment advice. ![]() William Blair On DocuSign's Stock: 'Sign Us Up' Here's What Wall Street Is Saying About SmartsheetĬiti: Ceridian Is 'Already Priced' For Its Market Share Potential LTX-Credence Corporation (NASDAQ: XCRA) was trading higher by 1.2 percent after the semiconductor test solution and electronics manufacturing solutions company reported its sixth consecutive quarterly earnings beat.Ģ0 Stocks Moving In Wednesday's Pre-Market SessionĪ Peek Into The Markets: US Stock Futures Tumble Ahead Of Fed Minutes The client told me that he received a call from someone in Kansas City. Benzinga Pro gives you everything you need for stock market news and research in an easy-to-use, customizable platform. The company said initial results found a statistically significant and clinically important blood pressure reduction in hypertensive patients. Im actually having the exact issue with a client of mine located in Dallas, TX. ![]() Medtronic PLC (NYSE: MDT) was trading flat after the company announced for the first time data from its SPYRAL HTN-ON MED study. 1 hour ago &0183 &32 Benzinga Pro Log In Data & APIs Events Marketfy Premarket Boost Advertise Contribute Español India Italiano Français Sign in Our Services News Earnings Guidance Dividends M&A Buybacks Legal. The medical-device company said it has received a Chinese patent from the local government for its ViRob technology platform. Microbot Medical Inc (NASDAQ: MBOT) was trading lower by 0.6 percent but was seen trading higher by more than 10 percent early in the pre-market session. As part of the agreement, the biopharmaceutical company that alleviates pain licensed worldwide rights (except U.S., Japan, and South Korea) to Vifor Pharma to commercialize its KORSUVA therapy to Vifor $70 million. Return on capital employed (ROCE) and return on assets (ROA) are two similar profitability ratios investors and. ![]() Cara Therapeutics Inc (NASDAQ: CARA) was trading higher by more than 20 percent in reaction to a new licensing agreement with Europe-based Vifor Pharma. According to Benzinga Pro, during Q3, MSCI. ![]()
0 Comments
Leave a Reply. |